Month: March 2019

Stickycell’s advanced Leukocyte Adhesive Function Assay (LAFA) is a new way to measure inflammation, a primary determinant of autoimmune diseases. Previously we’ve shown how circulating leukocytes in our blood become stickier and cause Multiple Sclerosis (MS) (Sticky Cell Series Article 4). In this article we will show how LAFA is applied in a clinical setting…

In a previous article (Article #5) we introduced StickyCell’s platform technology, Leukocyte Adhesive Function Assay (LAFA). Here we’ll explain how we measure inflammation using LAFA technology. Leukocyte recruitment from the blood to the surrounding tissue, a hallmark of inflammation, requires adhesion of the leukocytes to the blood vessel endothelial cells (Article #2). The stronger the…

Personalised medicine is a model of practicing medicine which involves disease diagnosis and choosing an optimal therapy based on the unique biological and physiological makeup of an individual. In theory, personalised medicine should radically improve the clinical outcome because it is so much more person-focussed. In reality, however, the practice of personalised medicine is currently…